Fortunately, in this study, we discovered that overexpressing miR-20b-5p combining Pembrolizumab enhanced the radiosensitivity of tumor cells by blocking the PD-L1/PD1 pathway (Figure 7). This evidence concerns the gene CD274 and neoplasm.